[1]
Schumann J,Henrich EC,Strobl H,Prondzinsky R,Weiche S,Thiele H,Werdan K,Frantz S,Unverzagt S, Inotropic agents and vasodilator strategies for the treatment of cardiogenic shock or low cardiac output syndrome. The Cochrane database of systematic reviews. 2018 Jan 29; [PubMed PMID: 29376560]
[2]
Kurmani S,Squire I, Acute Heart Failure: Definition, Classification and Epidemiology. Current heart failure reports. 2017 Oct; [PubMed PMID: 28785969]
[3]
DiBianco R, Acute positive inotropic intervention: the phosphodiesterase inhibitors. American heart journal. 1991 Jun; [PubMed PMID: 2035420]
[4]
Asif M, Phosphodiesterase-III Inhibitors Amrinone and Milrinone on Epilepsy and Cardiovascular Activities. North American journal of medical sciences. 2012 Oct; [PubMed PMID: 23112975]
[5]
Cruickshank JM, Phosphodiesterase III inhibitors: long-term risks and short-term benefits. Cardiovascular drugs and therapy. 1993 Aug; [PubMed PMID: 8241008]
[6]
Endoh M, Amrinone, forerunner of novel cardiotonic agents, caused paradigm shift of heart failure pharmacotherapy. Circulation research. 2013 Aug 2; [PubMed PMID: 23908328]
[7]
Fearnley CJ,Roderick HL,Bootman MD, Calcium signaling in cardiac myocytes. Cold Spring Harbor perspectives in biology. 2011 Nov 1; [PubMed PMID: 21875987]
[9]
Hellsten Y,Nyberg M,Jensen LG,Mortensen SP, Vasodilator interactions in skeletal muscle blood flow regulation. The Journal of physiology. 2012 Dec 15; [PubMed PMID: 22988140]
[10]
Hermiller JB,Leithe ME,Magorien RD,Unverferth DV,Leier CV, Amrinone in severe congestive heart failure: another look at an intriguing new cardioactive drug. The Journal of pharmacology and experimental therapeutics. 1984 Feb; [PubMed PMID: 6694112]
[11]
Treadway G, Clinical safety of intravenous amrinone--a review. The American journal of cardiology. 1985 Jul 22 [PubMed PMID: 3895878]
[13]
Ward A,Brogden RN,Heel RC,Speight TM,Avery GS, Amrinone. A preliminary review of its pharmacological properties and therapeutic use. Drugs. 1983 Dec; [PubMed PMID: 6360634]
[14]
Bottorff MB,Rutledge DR,Pieper JA, Evaluation of intravenous amrinone: the first of a new class of positive inotropic agents with vasodilator properties. Pharmacotherapy. 1985 Sep-Oct; [PubMed PMID: 3906583]
[15]
Silverman BD,Merrill AJ Jr,Gerber L, Clinical effects and side effects of amrinone. A study of 24 patients with chronic congestive heart failure. Archives of internal medicine. 1985 May; [PubMed PMID: 3994460]
[17]
Ansell J,Tiarks C,McCue J,Parrilla N,Benotti JR, Amrinone-induced thrombocytopenia. Archives of internal medicine. 1984 May; [PubMed PMID: 6712412]